|
|
Article: Thomas Jefferson University obtains United States patent.
- Article from:
- BIOTECH Patent News
- Article date:
- June 1, 2006
CopyrightCOPYRIGHT 2006 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Thomas Jefferson University (Philadelphia, PA) has patented live, attenuated recombinant rabies virus vaccines generated using reverse genetics to combine the antigenic determinants that render the rabies virus non-pathogenic with the determinants that are responsible for the elicitation of an effective anti-rabies immune response. These vaccines do not affect the antigenic, and therefore the immunogenic, properties of the virus. The ...
Related newspaper, magazine, and journal articles:
|
|
Article: Rabies Virus Vectors Induce T-Cell Response.
Gene Therapy Weekly;
April 26, 2001 ;
636 words
... ... strains of HIV ("Rabies virus-based vectors expressing ... suggest promise for [rabies virus]-based vectors ... Schnell, Thomas Jefferson University, Jefferson Medical ... study include: * Rabies-virus-based vectors show ...
|
|